Literature DB >> 16222030

High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon.

Sebastião Viana1, Raymundo Paraná, Regina Célia Moreira, Adriana Parise Compri, Vanise Macedo.   

Abstract

Severe cases of hepatitis caused by hepatitis B virus (HBV) or hepatitis D virus (HDV) are often seen in the Brazilian Amazon, but there is a paucity of epidemiologic studies on viral hepatitis in this area. Thus, a cross-sectional study to investigate the prevalence of markers for HBV and HDV was performed. Serum samples were collected after participants completed an epidemiologic questionnaire. Markers for HBV and HDV were analyzed with an enzyme-linked immunosorbent assay. The HBV genotype was determined by sequencing of the gene for hepatitis B surface antigen (HBsAg). Of 2,656 samples, 89 (3.3%) were positive for HBsAg and 1,628 (61.5%) were positive for IgG antibody to hepatitis B core antigen. Markers for HDV were found in 47 cases (1.7%). Antibodies to HDV were associated with Amerindian ethnic origin, a lower educational level, a history of acute viral hepatitis, a history of malaria, male sex, a history of tattooing, and older age. The most frequent HBV genotypes were A and F. This study showed a high prevalence of HBV and HDV in the western Brazilian Amazon, as well as the predominance of HBV genotypes A and F.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16222030

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

Review 1.  Hepatitis B virus epidemiology.

Authors:  Jennifer H MacLachlan; Benjamin C Cowie
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

2.  Full-genome sequences of hepatitis B virus subgenotype D3 isolates from the Brazilian Amazon Region.

Authors:  Natália Spitz; Francisco C A Mello; Natalia Motta Araujo
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-02-13       Impact factor: 2.743

Review 3.  Hepatitis delta virus: Making the point from virus isolation up to 2014.

Authors:  Raffaella Romeo; Riccardo Perbellini
Journal:  World J Hepatol       Date:  2015-10-08

Review 4.  Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in disease.

Authors:  Merrill Singer
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

5.  One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus.

Authors:  José Eduardo Levi; Ricardo Antonio D'Almeida Pereira; Márcia Bernardino de Carvalho Polite; Mariza Aparecida Mota; Silvia Patricia Nunez; João Renato Rebello Pinho; José Mauro Kutner
Journal:  Rev Bras Hematol Hemoter       Date:  2013

Review 6.  Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options.

Authors:  Florian A Lempp; Yi Ni; Stephan Urban
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

Review 7.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

Review 8.  Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.

Authors:  Heiner Wedemeyer; Michael P Manns
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01       Impact factor: 46.802

9.  Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon.

Authors:  Márcia da Costa Castilho; Cintia Mara Costa de Oliveira; João Bosco de Lima Gimaque; Jorge Di Tommaso Leão; Wornei Silva Miranda Braga
Journal:  Am J Trop Med Hyg       Date:  2012-08-20       Impact factor: 2.345

10.  Characterization of hepatitis B virus (HBV) genotypes in patients from Rondônia, Brazil.

Authors:  Alcione O Santos; Mónica V Alvarado-Mora; Lívia Botelho; Deusilene S Vieira; João R Rebello Pinho; Flair J Carrilho; Eduardo R Honda; Juan M Salcedo
Journal:  Virol J       Date:  2010-11-12       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.